Adherence to antiretroviral therapy in a context of universal access, in Rio de Janeiro, Brazil

AIDS Care - Psychological and Socio-Medical Aspects of AIDS/HIV

Volumn 19, Issue 6, 2007, Pages 740-748

  Remien, R H ^a   Bastos, F I ^b   Terto Jr , V ^c   Raxach, J C ^c   Pinto, R M ^a   Parker, R G ^a,c,d   Berkman, A ^a,d   Hacker, M A ^b  

^a NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

^b INSTITUTO OSWALDO CRUZ   (Brazil)

^c Brazilian Interdisciplinary AIDS Association (ABIA)   (Brazil)

^d New York State Psychiatric Institute ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ANOREXIA; ANTIVIRAL THERAPY; ARTICLE; BIVARIATE ANALYSIS; BRAZIL; CONTROLLED STUDY; DEMOGRAPHY; DOCTOR PATIENT RELATION; FEMALE; HEALTH CARE; HEALTH CARE ACCESS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PATIENT COMPLIANCE; PRIORITY JOURNAL; SELF CONCEPT; SELF REPORT; SEXUAL ORIENTATION; SOCIAL ASPECT; TEACHING HOSPITAL; UNITED STATES; WESTERN EUROPE;

ADULT; ANTI-RETROVIRAL AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; BRAZIL; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; MALE; MIDDLE AGED; PATIENT COMPLIANCE; PHYSICIAN-PATIENT RELATIONS;

EID: 34250672875     PISSN: 09540121     EISSN: 13600451     Source Type: Journal    
DOI: 10.1080/09540120600842516     Document Type: Article

References (38)

1. Arnsten, J.H., Demas, P.A., Farzadegan, H., Grant, R.W., Gourevitch, M.N., Chang, C.J., et al. (2001). Antiretroviral therapy adherence and viral suppression in HIV-infected drug users: Comparison of self-report and electronic monitoring. Clinical Infectious Diseases, 33, 1417-1423.
2. Bangsberg, D.R., Perry, S., Charlebois, E., Clark, R.A., Robertson, M., Zolopa, A.R., et al. (2001). Non-adherence to highly active antiretroviral therapy predicts progression to AIDS. AIDS, 15, 1181-1183.
3. Berkman, A., Garcia, J., Muñoz-Laboy, M., Paiva, V., & Parker, R. (2005). A critical analysis of the Brazilian response to HIV/AIDS: Lessons learned for controlling and mitigating the epidemic in developing countries. American Journal of Public Health, 95, 1162-1172.
4. Brazilian Ministry of Health (2005). Epidemiologic Bulletin AIDST. Available at: http://www.aids.gov.br/final/dados/BOLETIM2.pdf
5. Brigido, L.F., Rodriguez, R., Casseb, J., Oliveira, D., Rossetti, M., Menezes, P., et al. (2001). Impact of adherence to antiretroviral therapy in HIV-1-infected patients at a university public service in Brazil. AIDS Patient Care STDS, 15, 587-593.
6. Catz, S.L., Kelly, J.A., Bogart, L.M., Benotsch, E.G., &Mcailiffe, T.L. (2000). Patterns, correlates and barriers to medication adherence among persons prescribed new treatments for HIV disease. Health Psychology, 19, 124-133.
7. Chesney, M.A., Ickovics, J., Hecht, F.M., Sikipa, G., & Rabkin, J. (1999). Adherence: A necessity for successful HIV combination therapy. AIDS, 13, S271-S278.
8. Chesney, M.A., Ickovics, J.R., Chambers, D.B., Gifford, J., Neidig, B., & Zwickl, A.W. (2000). Self-reported adherence to antiretroviral medications among participants in HIV clinical trials: The AACTG adherence instruments. AIDS Care, 12, 255-266.
9. Cohen, J., & Cohen, P. (1983). Applied multiple regression/correlation analysis for the behavioral sciences (2nd edition). Hillside, New Jersey: Lawrence Erlbaum.
10. Crepaz, N., & Marks, G. (2002). Towards an understanding of sexual risk behavior in people living with HIV: A review of social, psychological and medical findings. AIDS, 25, 135-149.
11. Cutrona, C.E. (1989). Ratings of social support by adolescents and adult informants: Degree of correspondence and prediction of depressive symptoms. Journal of Personality and Social Psychology, 57, 723-730.
12. Fogarty, L., Roter, D., Larson, S., Burke, J., Gillespie, J., & Levy, R. (2002). Patient adherence to HIV medication regimens: A review of published and abstract reports. Patient Education & Counseling, 46, 93-108.
13. Garcia De Olalla, P., Knobel, H., Carmona, A., Gnelar, A., Lopez-Colmes, J.L., & Cayla, J.A. (2002). Impact of adherence and highly active antiretroviral therapy on survival in HIV-infected patients. Journal of Acquired Immune Deficiency Syndromes, 30, 105-110.
14. Gifford, A.G., Bormann, J.E., Shively, M.J., Wright, B.C., Richman, D.D., & Bozette, S.A. (2000). Predictors of self-reported adherence and plasma HIV concentrations in patients on multidrug antiretroviral regimens. Journal of Acquired Immune Deficiency Syndromes, 23, 386-395.
15. Hofer, C.B., Schecter, M., & Harrison, L.H. (2004). Effectiveness of antriretroviral therapy among patients who attend public HIV clinics in Rio de Janeiro, Brazil. Journal of Acquired Immune Deficiency Syndromes, 36, 967-971.
16. Howard, A.A., Arnsten, J.H., Lo, Y., Vlahov, D., Rich, J.D., Schuman, P., et al. (2002). A prospective study of adherence and viral load in a large multi-center cohort of HIV-infected women. AIDS, 16, 2175-2182.
17. Ickovics, J.R., & Meade, C.S. (2002). Adherence to HAART among patients with HIV: Breakthroughs and barriers. AIDS Care, 14, 309-318.
18. Justice, A. C., Holmes, W., Gifford, A. L., Rabeneck, L., Zackin, R., Sinclair, G., et al. (2001). Development and validation of a self-completed HIV symptom index. Journal of Clinical Epidemiology, S77-S90.
19. Mcnabb, J., Ross, J.W., Abriola, K., Turley, C., Nightingale, C.H., & Nicolau, D.P. (2001). Adherence to highly active antiretroviral therapy predicts outcome at an inner-city human immunodeficiency virus clinic. Clinical Infectious Diseases, 33, 700-705.
20. Mehta, S., Moore, R.D., & Graham, N.M. (1997). Potential factors affecting adherence with HIV therapy. AIDS, 11, 1665-1670.
21. Melbourne, K.M., Geletko, S.M., Brown, S.L., Wiley-Lessne, C., Chase, S., & Fisher, A. (1999). Medication adherence in patients with HIV infection: A comparison of two measurement methods. AIDS Reader, 9, 329-338.
22. Mocroft, A., Ledergerber, B., Katlama, C., Kirk, O., Reiss, P., D'arminio-Monforte, A., et al. (2003). Decline in the AIDS and death rates in the EuroSIDA study: An observational study. Lancet, 362, 22-29.
23. National Institute of Geography and Statistics (2005). Minimum Social Indicators. Available at: http://www.ibge.gov.br/
24. Nemes, A., Forster, T., & Csanady, M. (2004). Antiretroviral therapy adherence in Brazil. AIDS, 18, (Suppl. 3), S15-S20.
25. Palella, F.J., Delaney, K.M., Moorman, A.C., Loveless, M.O., Fuhrer, J., Satten, G.A., et al. (1998). Declining morbidity and mortality among patients with advanced HIV infection. New England Journal of Medicine, 338, 853-860.
26. Parker, R. (2003). Building the foundations for the response to HIV/AIDS in Brazil: The development of HIV/AIDS policy, 1982-1996. Debates on health issues, 27, 143-183. Rio de Janeiro: Centro Brasileiro de Estudos de Sau de Saúde.
27. Passareli, C.A., & Terto, V.Jr. (2003). Non-governmental organizations and access to anti-retroviral treatments in Brazil. Debates on health issues, 27, 252-264. Rio de Janeiro: Centro Brasileiro de Estudos de Saúde.
28. Paterson, D.L., Swindells, S., Mohr, J., Brester, M., Vergis, E.N., & Squier, C. (2000). Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Annals of Internal Medicine, 133, 21-30.
29. Pinheiro, C.A.T., De-Carvalho-Leite, J.C., Drachler, M.L., & Silveira, V.L. (2002). Factors associated with adherence to antiretroviral therapy in HIV/AIDS patients: A cross-sectional study in southern Brazil. Brazilian Journal of Medical and Biological Research, 35, 1173-1181.
30. Remien, R.H. (1998). Adhering to HIV combination therapy: The role of the pharmacist. Pharmacy Times, 5, 28-37.
31. Remien, R.H., Stirratt, M.J., Dolezal, C., Dognin, J.S., Wagner, G.J., Carballo-Dieguez, A., et al. (2005). Couple-focused support to improve HIV medication adherence: A randomized controlled trial. AIDS, 19, 807-814.
32. Remien, R.H., Hirky, L., Johnson, M., Weinhardt, L., Whittier, D., & Le, M.G. (2003). Adherence to medication treatment: A qualitative study of facilitators and barriers among a diverse sample of HIV-positive men and women in four US cities. AIDS and Behavior, 7, 61-72.
33. Sepkowitz, K. (2001). AIDS: The first 20 years. New England Journal of Medicine, 344, 1764-1772.
34. Stall, R., Hoff, C., Coates, T.J., Paul, J, Phillips, K.A., Ekstrand, M., et al. (1996). Decisions to get HIV tested and to accept antiretroviral therapies among gay/bisexual men: Implications for secondary prevention efforts. Journal of Acquired Immune Deficiency Syndromes, 11, 151-160.
35. Teixeira, P. R. (2003). Universal access to AIDS medicines: The Brazilian response. Debates on health issues, 27, 184-191. Rio de Janeiro: Centro Brasileiro de Estudos de Saúde.
36. Vitória, M.A.V. (2003). The experience of providing universal access to ARV drugs in Brazil.
37. Debates on health issues, 27, 247-251. Rio de Janeiro: Centro Brasileiro de Estudos de Saúde.
38. Wood, E., Hogg, R.S., Yip, B., Harrigan, P.R., O'Shaughnessy, M.V., & Montaner, J.S. (2003). Effect of medication adherence on survival of HIV-infected adults who start highly active antiretroviral therapy when the CD4+/ cell count is 0.200 to 0.350 x 10(9) cells/L. Annals of Internal Medicine, 139, 810-816.